View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Rituximab 375 / Lenalidomide 20, Mantle Cell Lymphoma Cycle 2+
Protocol-ID: 324 V1.0 (Mini), RITU375/LENA20 - LENA20 maint., MCL C2+Indication(s)
- Mantle Cell Lymphoma; ICD-10 C83.1
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 22.01.2015